Processa Pharmaceuticals Statistics
NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.42-0.09 (-5.96%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Processa Pharmaceuticals by the numbers
Processa Pharmaceuticals has a market capitalization of $4.0 million based on 2.79M shares outstanding. With trailing EPS of $-4.33, Processa Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.2% below its 50-day average and 43.2% below its 200-day average.
Average daily trading volume is 224.79K shares, or about $319,202 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PCSA valuation vs. peer median
| Metric | PCSA | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.97M | $3.81M | +4% |
| Avg. volume | 224.79K | 424.00K | -47% |
Peer median across 8 companies: ERNA, GRI, SXTP, JUNS, SXTC, RDHL, EOCN, HCWB.
Valuation
- Market cap
- $3.97M
- EPS (TTM)
- $-4.33
- Shares outstanding
- 2.79M
Price and trading
- Previous close
- 1.51
- Open
- 1.49
- Day range
- 1.41 – 1.49
- 52-week range
- 1.41 – 11.08
- Beta
- —
- Volume
- 12.81K
- Average volume
- 224.79K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 3.97M
- Forward Pe
- -0.38
- Eps
- -4.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.08
- Week52 Low
- 1.41
- Avg Volume
- 224.79K
- Shares Outstanding
- 2.79M
- Ma50
- 2.03
- Ma200
- 2.50
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -87.18%
- Pct From52w Low
- 0.71%